Effect of age on postmyocardial infarction ventricular arrhythmias (Holter Registry data from CAST I and CAST II).

R A Josephson1, L A Papa, M M Brooks

  • 1CAST Investigators, Akron, Ohio, USA.

Insights

Older age significantly increases ventricular ectopy after myocardial infarction. Ventricular premature complexes (VPCs) and ventricular tachycardia (VT) incidence and frequency rise with age in post-MI patients.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Geriatric Medicine

Background:

  • Post-myocardial infarction (MI) patients are at increased risk for ventricular arrhythmias.
  • Age is a known risk factor for cardiovascular diseases, but its specific impact on ventricular ectopy in MI survivors requires detailed investigation.

Purpose of the Study:

  • To investigate the association between age and the incidence and frequency of ventricular premature complexes (VPCs) and ventricular tachycardia (VT) in patients who have experienced a myocardial infarction.
  • To determine if age is an independent predictor of ventricular ectopy in this population.

Main Methods:

  • Analysis of Holter monitoring data from 17,609 patients within the CAST Registry.
  • Multivariable regression analysis to assess the relationship between age and ventricular ectopy, adjusting for other potential confounders.

Main Results:

  • Age was identified as a significant independent predictor of increased ventricular ectopy.
  • The median hourly rate of VPCs increased from 0.4 in patients younger than 50 years to 4.0 in those aged 75-80 years.
  • The prevalence of VT increased from 7.3% in patients younger than 50 years to 15.3% in those aged 75-80 years.

Conclusions:

  • Advanced age is a critical independent risk factor for developing ventricular ectopy, including VPCs and VT, in the post-myocardial infarction population.
  • Clinical monitoring and management strategies for ventricular arrhythmias in MI survivors should consider the heightened risk associated with older age.

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers01:24

Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers

Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which indirectly block calcium...
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Holter Monitor: 24-Hour Monitoring01:23

Holter Monitor: 24-Hour Monitoring

Holter monitoring is a continuous electrocardiography (ECG) recording that tracks the heart's electrical activity over an extended period, generally 24 to 48 hours. This noninvasive diagnostic tool detects irregular heart rhythms that may not be captured during a standard ECG performed in a clinical setting.DeviceThe Holter monitor is a portable, small device connected to several electrodes on the patient's chest. These electrodes detect the heart's electrical signals and transmit them to the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...